Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Preliminary results of a phase ii study of Brentuximab vedotin using a response adapted design in the first line treatment of patients with Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or co-morbidity (BREVITY)

Lookup NU author(s): Dr Tobias Menne

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Gibb A, Pirrie S, Linton K, Paterson K, Davies A, Collins G, Menne T, Mckay P, Fields P, Miall F, Nagy E, Wheatley K, Warbey V, Barrington S, Radford J

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 10th International Symposium on Hodgkin Lymphoma

Year of Conference: 2016

Pages: 20-20

Print publication date: 01/01/2016

Acceptance date: 02/04/2016

ISSN: 0390-6078

Publisher: Fondazione Ferrata Storti

URL: http://www.haematologica.org/content/101/s5/1

Series Title: Haematologica

Share